Clinical Trial Update: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for Enhanced Angiogenic Cell Therapy in patients with acute myocardial infarction; the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Enhanced Angiogenic Cell Therapy

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Anterior Wall Myocardial Infarction | Phase 2 | Status: ACTIVE_NOT_RECRUITING